Acacia stockholder plans sale of 24,000 shares

Rhea-AI Filing Summary

ACACIA RESEARCH CORP (ACTG) received a Rule 144 notice indicating that stockholder Isaac T. Kohlberg plans to sell up to 24,000 shares of Common Stock, with an approximate aggregate market value of $110,000, as of September 15, 2026, on the Nasdaq Global Select market.

The notice also reports that Kohlberg previously received 30,534 restricted shares from the issuer on May 26, 2023 for services rendered, and that 32,188 shares of Common Stock were sold during the past three months for $150,318.

Key Figures

Shares proposed to be sold: 24,000 shares Aggregate market value of proposed sale: $110,000 Shares sold in past 3 months: 32,188 shares +2 more

5 metrics

Shares proposed to be sold 24,000 shares Common Stock planned for sale under Rule 144 as of September 15, 2026

Aggregate market value of proposed sale $110,000 Estimated value of 24,000 shares of Common Stock

Shares sold in past 3 months 32,188 shares Common Stock sold on August 12, 2026

Proceeds from past 3-month sale $150,318 Aggregate amount received for 32,188 shares sold on August 12, 2026

Restricted stock grant 30,534 shares Grant of restricted stock from issuer on May 26, 2023 for services rendered

Key Terms

Rule 144, restricted stock, Nasdaq Global Select

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"Grant of restricted stock | Issuer | | | 30534 | 05/26/2023"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Nasdaq Global Select market

"09/15/2026 | Nasdaq Global Select"

A Nasdaq Global Select listing is the highest-quality tier on the Nasdaq stock exchange, awarded to companies that meet the strictest financial, reporting and governance standards. Think of it as a “premium shelf” in a store: it signals stronger oversight, transparency and liquidity compared with lower tiers, which helps investors judge company reliability, compare risk, and may attract more institutional buyers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for ACACIA RESEARCH (ACTG)?

The filing states that stockholder Isaac T. Kohlberg plans to sell up to 24,000 shares of ACACIA RESEARCH CORP common stock under Rule 144, with an estimated market value of $110,000 as of September 15, 2026.

How many ACTG shares are proposed to be sold under this Form 144?

The notice indicates a proposed sale of up to 24,000 shares of ACACIA RESEARCH CORP common stock, with an approximate aggregate market value of $110,000 as of September 15, 2026.

Who is selling the ACACIA RESEARCH (ACTG) shares in this Form 144?

The securities are to be sold for the account of Isaac T. Kohlberg, identified in the filing in connection with ACACIA RESEARCH CORP and described in relation to the issuer’s director information.

What prior ACTG share sales by Isaac T. Kohlberg are disclosed?

The filing reports that 32,188 shares of ACACIA RESEARCH CORP common stock were sold on August 12, 2026 for an aggregate amount of $150,318 during the past three months.

How did Isaac T. Kohlberg originally acquire some of the ACTG shares?

The filing states that 30,534 shares of ACACIA RESEARCH CORP common stock were acquired on May 26, 2023 as a grant of restricted stock from the issuer for services rendered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 02:25 PM Accepted by SEC EDGAR 09/15/2026 - 02:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001776505
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ACACIA RESEARCH CORP
SEC File Number	001-37721
Address of Issuer	777 3RD AVENUE SUITE 2602 NEW YORK NEW YORK 10017
Phone	332-236-8500
Name of Person for Whose Account the Securities are To Be Sold	Kohlberg Isaac T.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Roy | Tedeschi | Schmidt Private Wealth &Partners 280 Summer Street 9th Floor Boston MA 02210	24000	110000.00	97586805	09/15/2026	Nasdaq Global Select

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/26/2023	Grant of restricted stock	Issuer			30534	05/26/2023	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Isaac T. Kohlberg 777 Third Avenue Suite 2602 New York NY 10017	Common Stock	08/12/2026	32188	150318.00

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Graff
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)